Cargando…
Updated Perspectives on Pulmonary Hypertension in COPD
Pulmonary hypertension (PH) is a frequent and important complication of chronic obstructive pulmonary disease (COPD). It is associated with worse clinical courses with more frequent exacerbation episodes, shorter survival, and greater need of health resources. PH is usually of moderate severity and...
Autores principales: | Blanco, Isabel, Tura-Ceide, Olga, Peinado, Victor Ivo, Barberà, Joan Albert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293405/ https://www.ncbi.nlm.nih.gov/pubmed/32606641 http://dx.doi.org/10.2147/COPD.S211841 |
Ejemplares similares
-
Association Between Systemic and Pulmonary Vascular Dysfunction in COPD
por: Piccari, Lucilla, et al.
Publicado: (2020) -
Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways
por: Aguilar, Daniel, et al.
Publicado: (2022) -
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023) -
Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19
por: Rodríguez, Cristina, et al.
Publicado: (2021) -
Atrophy signaling pathways in respiratory and limb muscles of guinea pigs exposed to chronic cigarette smoke: role of soluble guanylate cyclase stimulation
por: Peinado, Víctor Ivo, et al.
Publicado: (2023)